Which Endpoints to Use in Clinical Trials in Venous Thromboembolism?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 108-108

Karger

Access to resources Recommend Favorite

Cancer and Venous Thromboembolism. Clinical Implications of Strong Association

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 1-2, 2006-06 ,pp. : 111-115

Karger

Access to resources Recommend Favorite

Clinical Validation of the AHRQ Postoperative Venous Thromboembolism Patient Safety Indicator

By Henderson Katherine E.   Recktenwald Angela J.   Reichley Richard M.   Bailey Thomas C.   Waterman Brian M.   Diekemper Rebecca L.   Storey Patricia E.   Ireland Belinda K.   Dunagan Wm. Claiborne  

Joint Commission Journal on Quality and Patient Safety, Vol. 35, Iss. 7, 2009-07 ,pp. : 370-376

Joint Commission Resources

Access to resources Recommend Favorite

Comparison of Clinical Characteristics and Outcomes of Patients with COPD Exacerbation with or without Venous Thromboembolism

By  

Respiration, Vol. 73, Iss. 4, 2006-07 ,pp. : 428-433

Karger

Access to resources Recommend Favorite

Venous Thromboembolism and Pancreatic Cancer: Incidence, Pathogenesis and Clinical Implications

By  

Oncology Research and Treatment, Vol. 31, Iss. 3, 2008-02 ,pp. : 129-135

Karger

Access to resources Recommend Favorite